Clinical Trial Update: Nectero EAST System Clinical Study [Phase 2, Phase 3]

View source ↗

Summary

Nectero Medical's EAST System is undergoing a Phase 2/3 clinical study for abdominal aortic aneurysm and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• Nectero EAST System

Snippet

Sponsor: Nectero Medical, Inc. | Conditions: Abdominal Aortic Aneurysm | Phase 2, Phase 3 | Status: RECRUITING